Skip to main content

Table 1 Distribution characteristics of covariates in patients who received RBC transfusion or did not receive RBC transfusion before and after propensity score matching

From: Perioperative red blood cell infusion and deep vein thrombosis in patients with femoral and pelvic fractures: a propensity score matching

Covariates

Before matching

  

After matching

  

Nontransfusion

Transfusion

  

Nontransfusion

Transfusion

  

(N=360)

(N=209)

χ2

P Value

(N=126)

(N=126)

χ2

P Value

Gender

 Male

152

42.20%

76

36.40%

1.890

0.169

44

34.92%

42

33.33%

0.071

0.790

 Female

208

57.80%

133

63.60%

  

82

65.08%

84

66.67%

  

Age-group(y)

 ≤60

87

24.20%

76

36.40%

12.121

0.002

32

25.40%

35

27.78%

3.400

0.183

 60-70

62

17.20%

21

10.00%

  

22

17.46%

12

9.52%

  

 >70

211

58.60%

112

53.60%

  

72

57.14%

79

62.70%

  

Drinking history

 No

289

80.30%

172

82.30%

0.350

0.554

110

87.30%

105

83.33%

0.792

0.374

 Yes

71

19.70%

37

17.70%

  

16

12.70%

21

16.67%

  

Smoking history

 No

273

75.80%

164

78.50%

0.516

0.473

103

81.75%

101

80.16%

0.103

0.748

 Yes

87

24.20%

45

21.50%

  

23

18.25%

25

19.84%

  

BMI (kg/m2)

 ≤18

47

13.10%

43

20.60%

5.711

0.058

23

18.25%

24

19.05%

1.262

0.532

 18-25

245

68.10%

132

63.20%

  

87

69.05%

80

63.49%

  

 >25

68

18.90%

34

16.30%

  

16

12.70%

22

17.46%

  

Pulmonary diseases

 No

308

85.60%

167

79.90%

3.062

0.080

101

80.15%

102

80.95%

0.025

0.874

 Yes

52

14.40%

42

20.10%

  

25

19.84%

24

19.04%

  

Hyperlipemia

 No

348

96.70%

206

98.60%

1.856

0.853

122

96.83%

124

98.41%

0.171

0.679

 Yes

12

3.30%

3

1.40%

  

4

3.17%

2

1.59%

  

Hypertension

 No

254

70.60%

155

74.20%

0.851

0.356

95

75.40%

90

71.43%

0.508

0.476

 Yes

106

29.40%

54

25.80%

  

31

24.60%

36

28.57%

  

Coronary heart disease

 No

320

88.90%

189

90.40%

0.333

0.564

114

90.48%

109

86.51%

0.974

0.324

 Yes

40

11.10%

20

9.60%

  

12

9.52%

17

13.49%

  

Diabetes

 No

296

82.20%

172

82.30%

0.001

0.982

106

84.13%

104

82.54%

0.114

0.735

 Yes

64

17.80%

37

17.70%

  

20

15.87%

22

17.46%

  

Hepatic diseases

 No

292

81.10%

182

87.10%

3.389

0.066

111

88.10%

103

81.75%

1.983

0.159

 Yes

68

18.90%

27

12.90%

  

15

11.90%

23

18.25%

  

Renal diseases

 No

307

85.30%

178

85.60%

0.009

0.923

107

84.92%

104

82.54%

0.262

0.609

 Yes

53

14.70%

30

14.40%

  

19

15.08%

22

17.46%

  

Malignant tumor

 No

324

90.00%

191

91.40%

0.296

0.586

111

88.10%

112

88.89%

0.039

0.844

 Yes

36

10.00%

18

8.60%

  

15

11.90%

14

11.11%

  

Hypoproteinemia

 No

348

96.67%

181

86.60%

22.056

0.000

117

92.86%

117

92.86%

0.000

1.000

 Yes

11

3.06%

28

13.40%

  

9

7.14%

9

7.14%

  

Anemia

 No

244

67.80%

63

30.10%

75.385

0.000

55

43.65%

56

44.44%

0.016

0.899

 Yes

116

32.20%

146

69.90%

  

71

56.35%

70

55.56%

  

ASA classification

 ≤2

94

26.10%

35

16.70%

6.615

0.010

26

20.63%

27

21.43%

0.024

0.877

 >2

266

73.90%

174

83.30%

  

100

79.37%

99

78.57%

  

Operative time(h)

 ≤2

275

76.40%

83

39.70%

76.236

0.000

72

57.14%

70

55.56%

0.065

0.799

 >2

85

23.60%

126

60.30%

  

54

42.86%

56

44.45%

  

Time from trauma to surgery(d)

 <4

193

53.60%

85

40.70%

8.863

0.003

61

48.41%

65

51.59%

0.254

0.614

 >4

167

46.40%

124

59.30%

  

65

51.59%

61

48.41%

  

Tranexamic acid

 No

100

27.80%

77

36.80%

5.070

0.024

41

32.54%

44

34.92%

0.160

0.689

 Yes

260

72.20%

132

63.20%

  

85

67.46%

82

65.08%

  

Anticoagulation

 No

10

2.80%

9

4.30%

0.957

0.328

3

2.38%

3

2.38%

0.000

1.000

 Yes

350

97.20%

200

95.70%

  

123

97.62%

123

97.62%